Use of drug treatments for Alzheimer's disease in France: a study on a national level based on the National Alzheimer's Data Bank (Banque Nationale Alzheimer)
Pharmacoepidemiology and Drug Safety, 07/11/2012
Tifratene K et al. – Four of five prescriptions for treatment with anti–Alzheimer's drugs complied with the specific drug treatment chapter of the 2008 French clinical guidelines. Prescriptions not complying with the guidelines for acetylcholinesterase inhibitors and memantine were usually issued in situations involving advanced–stage Alzheimer's disease. The BNA can provide precise information on medical practice in Alzheimer's disease and related disorders.